Publications by authors named "J W Drijfhout"

A group of bacterial proteases, the Pro-Pro endopeptidases (PPEPs), possess the unique ability to hydrolyze proline-proline bonds in proteins. Since a protease's function is largely determined by its substrate specificity, methods that can extensively characterize substrate specificity are valuable tools for protease research. Previously, we achieved an in-depth characterization of PPEP prime-side specificity.

View Article and Find Full Text PDF

The antibiotic management of catheter-related infections (CRIs) often fails owing to the emergence of antimicrobial-resistant strains and/or biofilm/persister apparitions. Thus, we investigated the efficacy of two novel antimicrobial agents, i.e.

View Article and Find Full Text PDF
Article Synopsis
  • Autoantibodies against complement component C1q are linked to autoimmune diseases like systemic lupus erythematosus and specifically bind to solid-phase C1q rather than its fluid form, indicating that normal C1q levels are maintained in affected patients.
  • Researchers isolated B cells that produce C1q-reactive antibodies and created nine monoclonal antibodies (mAbs) that display high affinity for the collagen-like region of C1q, recognizing multiple natural ligands and specific epitopes.
  • These anti-C1q mAbs enhance phagocytic activity against immune complexes without promoting complement activation, suggesting their role in autoimmune conditions may involve increased immune response through Fc-receptor-mediated functions.
View Article and Find Full Text PDF

Antimicrobial peptides (AMPs) are promising alternatives to antibiotics for treatment of antimicrobial resistant (AMR) bacterial infections. However, their narrow therapeutic window due to in vivo toxicity and limited stability hampers their clinical use. Here, we evaluated encapsulation of two amphiphilic AMPs, SAAP-148 and snake cathelicidin Ab-Cath, into oleyl-modified hyaluronic acid (OL-HA) nanogels to improve their selectivity index.

View Article and Find Full Text PDF

Synthetic antibacterial and anti-biofilm peptide (SAAP)-148 was developed to combat bacterial infections not effectively treatable with current antibiotics. SAAP-148 is highly effective against antimicrobial-resistant bacteria without inducing resistance; however, challenges for further development of SAAP-148 include its cytotoxicity and short circulation half-life. To circumvent these drawbacks, a library of SAAP-148 linked to polyethylene glycol (PEG) groups of various lengths was synthesized and screened for in vitro antibacterial activity and hemolytic activity.

View Article and Find Full Text PDF